Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh

globenewswire.com

Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Japan In Vitro Diagnostics Market: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Industry Trends and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.

The Japan in vitro diagnostics (IVD) market is poised for significant expansion, with projections indicating growth from USD 3.30 billion in the current year to USD 5.28 billion by 2035, at a compound annual growth rate (CAGR) of 5.4% through the forecast period.

The IVD sector encompasses laboratory tests on human samples, critical for disease identification, monitoring disease progression, and predicting healthcare outcomes. Despite stringent regulations due to their impact on healthcare, IVD solutions range from home-use glucose monitors to advanced lab-based diagnostics, including blood tests, cancer screenings, and kidney profiling.

According to the World Health Organization, the market hosts over 40,000 IVD products, underlining their importance in healthcare, as more than 70% of medical decisions are based on laboratory results. This sector's growth is driven by Japan's aging population, which demands increased diagnostic testing for chronic diseases like diabetes, cancer, and cardiovascular ailments. Innovations in AI, automation, precision medicine, genetic testing, and point-of-care are further enhancing the market by improving accuracy and efficiency.

Growth Drivers: Strategic Enablers of Market Expansion

The IVD market in Japan benefits from several growth factors, including technological advancements, supportive government policies, higher healthcare expenditure, and preventive health initiatives. Investments in R&D also play a crucial role in market expansion.

Market Challenges: Critical Barriers Impeding Progress

Despite the potential for growth, the market grapples with challenges such as stringent PMDA regulations, high R&D costs, and clinical trial expenses. Financial constraints due to complex reimbursement systems and burdened hospital budgets limit accessibility. Additionally, supply chain issues, skilled workforce shortages, pricing pressures, and technological adoption resistance impede progress.

Laboratory Tests: Leading Market Segment

Laboratories currently dominate with 85% of the market, attributed to their capability for extensive and complex testing. However, point-of-care testing is anticipated to experience more rapid growth, with a CAGR of 4% in the forecast period.

Reagents: Dominating Market Segment

Reagents maintain the majority market share (~75%) due to a high-volume, consumable-driven business model, important for clinical chemistry, immunoassay, and hematology sectors. Despite this, the instruments segment is poised for higher growth during the forecast period.

Reasons to Buy this Report

Players in the Japan In Vitro Diagnostics Market:

Japan In Vitro Diagnostics Market: Key Segments

Test Type:

Type of Offering:

Type of Technology:

Therapeutic Area:

End Users:

Complementary Benefits

Key Attributes:

For more information about this report visit https://www.researchandmarkets.com/r/6uberx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.